Recent Company News

• 01:39 AM ET Nov 05, 2025
  

  Medipal Holdings reports H1 net income attributable ¥22.09B, +2% vs year-ago ¥21.73B (¥2550.0000, 0)

• 03:54 AM ET Sep 29, 2025
  

  Japan's MHLW grants orphan drug designation to JCR Pharmaceuticals and Medipal Holdings' JR-446 for MPS IIIB (¥646.0000, 0)

• 12:15 AM ET Sep 09, 2025
  

  StreetAccount Summary: Asian stocks reaching new 52-week highs/lows (159 total)

• 10:56 PM ET Sep 08, 2025
  

  StreetAccount Summary: Japan Stocks reaching new 52-week highs/lows (227 total)

• 11:52 PM ET Sep 07, 2025
  

  StreetAccount Summary: Asian stocks reaching new 52-week highs/lows (170 total)

• 11:10 PM ET Sep 07, 2025
  

  StreetAccount Summary: Japan Stocks reaching new 52-week highs/lows (311 total)

• 02:40 AM ET Aug 29, 2025
  

  JCR Pharmaceuticals and MEDIPAL enter global licensing deal and partnership in Japan for JR-479 (¥621.0000, 0)

• 11:00 PM ET Aug 20, 2025
  

  StreetAccount Summary: Japan Stocks reaching new 52-week highs/lows (113 total)

• 12:15 AM ET Aug 20, 2025
  

  StreetAccount Summary: Asian stocks reaching new 52-week highs/lows (81 total)

• 11:11 PM ET Aug 19, 2025
  

  StreetAccount Summary: Japan Stocks reaching new 52-week highs/lows (47 total)